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An endophytic fungus isolated from the plant Cinnamomum mollissimum was investigated for the bioactivity of its metabolites.
The fungus, similar to a Phoma sp., was cultured in potato dextrose broth for two weeks, followed by extraction with ethyl acetate.
The crude extract obtained was fractionated by high-performance liquid chromatography. Both crude extract and fractions were
assayed for cytotoxicity against P388 murine leukemic cells and inhibition of bacterial and fungal pathogens. The bioactive extract
fraction was puriﬁed further and characterized by nuclear magnetic resonance, mass spectral and X-ray crystallography analysis.
A polyketide compound, 5-hydroxyramulosin, was identiﬁed as the constituent of the bioactive fungal extract fraction. This com-
pound inhibited the fungal pathogen Aspergillus niger (IC50 1.56μg/mL) and was cytotoxic against murine leukemia cells (IC50
2.10μg/mL).5-Hydroxyramulosinwasthemajorcompoundproducedbytheendophyticfungus.Thisresearchsuggeststhatfungal
endophytes are a good source of bioactive metabolites which have potential applications in medicine.
1.Introduction
Endophytic fungi live within plant tissue without causing
apparent injury or symptoms to the host plant [1]. Some of
these endophytes provide protection to their host plant from
tissue-invading pathogens [2]. They are known to produce
secondary metabolites with pharmacological importance
such as antibiotic, antiviral, antidiabetic, and antiinﬂamma-
tory compounds [3–6]. In some cases, endophytes in plants
havebeenfoundtoproducesimilarcompoundsashostplant
[7].
The genus Cinnamomum belongs to the family Laurace-
ae. There are 21 species of Cinnamomum in Peninsular Ma-
laysia [8]. Plants of this genus such as C. zelyanicum and C.
cassia have been extensively used as antiseptic agents [9–11]
andtotreatbronchitis,cold,andsinusinherbaltherapy[12].
Products of the plant such as cinnamon powder have been
reported to possess minor antibacterial and antifungal activ-
ities on the skin [13]. Essential oil extract of C. mollissimum
leaf has been found to have broad antifungal activity [14].
Recent ﬁndings describe the anticancer property of a con-
stituent from C. kotoense leaf. This explains why plants of
these species are also used to treat warts and certain can-
cerous tumours [15].
As plants of Cinnamomum species have medicinal value,
endophytic fungi from C. mollissimum were isolated and
screened for antimicrobial activity. One endophytic fungal
isolatewasthenselectedtofurtherevaluateitsbiologicalacti-
vity and to identify the bioactive compound which gives rise
to the activity.2 Evidence-Based Complementary and Alternative Medicine
2. Methods
2.1. Isolation of Endophytic Fungi. Endophytic fungi were
isolated from the plant C. mollissimum which was sampled
at Universiti Kebangsaan Malaysia Forest Reserve, Selangor,
Malaysia. The plant specimen voucher number 955 was de-
posited in the herbarium of Universiti Kebangsaan Malaysia.
Plant leaf and stem pieces were surface sterilized [16]a n d
cultured on potato dextrose agar and water agar to isolate
endophytic fungi.
2.2. Preliminary Screening for Antimicrobial Activity. All fun-
gal isolates recovered from the plant were screened for anti-
microbial activity by using a modiﬁed agar plate-based assay
[17]. In this assay, the fungal isolate was grown on potato
dextrose agar (PDA) at 27◦C for 14 days. The target organ-
isms were streaked radial to the original growth of the fun-
gal isolate in the centre of the plate. The target organisms
comprising of bacterial and fungal pathogens were Staphylo-
coccus aureus, Bacillus subtilis, Escherichia coli, Pseudomonas
aeruginosa, Candida albicans, Aspergillus niger, Trichoderma
viridae, Fusarium solani, and Aspergillus fumigatus. Antimi-
crobial activity was determined as growth inhibition of the
target organism.
2.3. Extraction of Fungal Metabolites. One fungal isolate,
coded as CB 007 (WA), which showed antimicrobial activity
was selected for further evaluation. The fungus was cultured
in200mLofpotatodextrosebrothwithshakingmodeat140
rotations per minute, for two weeks at 27◦C. The culture
broth and mycelia were separated by ﬁltration where the
broth was extracted with an equal amount of ethyl acetate
overnight. The fresh solvent extract was concentrated with a
rotary evaporator to obtain a crude extract.
2.4. Fractionation of Crude Extract. An aliquot of the crude
extract (250μg) was analyzed by reverse phase C18 high-per-
formance liquid chromatography (HPLC) using the follow-
ing gradient solvent system: 2 minutes (min) at 10% ace-
tonitrile (ACN)/miliQ water (H2O); a linear gradient to 75%
ACN/H2O over 12min; isocratic at 75% for another 10min;
a linear gradient for 2min to 100% ACN, isocratic at 100%
ACN for 4min then returned to 10% ACN/H2Oo v e r2m i n
and reequilibrated for 8min; with a ﬂow rate 1mL/min. The
cycle lasted for 40min, and the eluant was collected from
2.92min to 24.92min into 96-well polystyrene microtitre
plates. A total of 88 fractions were collected, each fraction
containing 250μL of sample. HPLC was performed on a
Dionex system equipped with an ISCO Foxy Jr. sample col-
lector using a reversed phase analytical column (Phenome-
nex Prodigy C18, 4.6 × 250mm, 5μm) with photodiode ar-
ray and evaporative light scattering detection (Alltech).
2.5.CytotoxicityAssay. Thecytotoxicityassaywascarriedout
on HPLC fractions according to methods previously des-
cribed [18]. A total of 88 fractions in a microtitre plate were
collected from HPLC analysis. Preparation of a daughter
plate was made by transferring 50μL of extract fraction from
each well of the master plate into another microtitre plate.
The solvent was evaporated from the daughter plate by using
a centrifugal evaporator machine before analysis for cytotox-
icity against P388 murine leukaemia cells. For the P388 cyto-
toxicity assay, the following medium was used: β-Me-thox-
yethoxymethyl, fetal calf serum (10%), penicillin (266μg/mL),
streptomycin (132μg/mL), L-glutamine (2mM), NaHCO3
(2.2g/L),4-(2-hydroxyethyl)-1-piperazineethanesulfonicacid
(7.4mM). The plate was incubated at 36◦C for 3 days. After
that, 20μL of thiazolyl blue tetrazolium (MTT) solution
(3.8mg/mL in phosphate buﬀered saline) was added to every
well and the plate was incubated for 4 hours at 36◦C. The
formazon product was dissolved in hydrochloric acid in iso-
propanol (170μL, 0.08M). Cell viability was determined
by measuring the absorbance of every well at 540nm. The
absorbance of cell free control and the analyte free cell con-
trol was taken as 0% and 100% growth reference, respec-
tively.
2.6. Antimicrobial Assay. A microtiter plate with HPLC frac-
tions was prepared in the same way as for the P388 cyto-
toxicity assay. After evaporation of solvent in the microtitre
plate, each well was added with 5% v/v methanol in water
(10μL), suspension of test organisms (40μL; 5 × 105 colony
formingunit(CFU)/mLforB.subtilisand2.5×103 CFU/mL
for A. niger and A. fumigatus), and medium (50μL; RPMI-
1640 for A. niger, A. fumigates, and Mueller Hinton broth for
B. subtilis). After incubation (27◦C; 48 hours for A. niger, A.
fumigatus and 37◦C; 24 hours for B. subtilis), an MTT solu-
tion (20μL; 5mg/mL) was added to all wells and further in-
cubated (27◦C; 4 hours). Subsequent to incubation, the for-
mazon product was dissolved in dimethyl sulfoxide (100μL).
Cell viability percentage was determined by measuring the
absorbance of every well at 540nm and subtracting the
absorbance of cell free control. The absorbance of cell free
control (solvent solution + medium) and the analyte free cell
control (solvent solution + test organisms in medium) was
taken as 0% and 100% growth reference, respectively. Cell
growth inhibition was calculated as 100%—cell viability %.
2.7. Isolation of Bioactive Compound. Following determina-
tion of cytotoxic and antimicrobial activities of HPLC frac-
tions, one bioactive fraction was selected for compound iso-
lation. The active compound in this fraction as determined
by its UV proﬁle was collected via HPLC method using the
same system as for the fractionation of crude extract. The
active compound was collected manually in vials using its
retentiontimeandUVproﬁleasareference.Thisprocesswas
repeated up to ten times to obtain suﬃcient amount of the
compound for structure elucidation. The sample was con-
centrated by blowing nitrogen gas onto the sample placed on
a heating block set at approximately 30◦C.
2.8. Structure Elucidation of the Bioactive Compound. NMR
and mass spectrometry experiments were carried out on the
bioactive compound. The NMR experiments, hydrogen 1
NMR, correlation spectroscopy, total correlation spectrosco-
py, heteronuclear single quantum coherence, heteronuclear
multiplebondcorrelation,wererecordedonaVarianINOVAEvidence-Based Complementary and Alternative Medicine 3
500 spectrometer at 23◦C, operating at 500MHz at 23◦C,
using a Capillary probe. Meanwhile, high resolution elec-
trospray lonisation mass spectra (HRESIMS) were obtained
on a Micromass liquid chromatography time-of-ﬂight mass
spectrometer.
The bioactive compound formed crystals when solvent
from the compound sample was evaporated overnight using
nitrogengasat8to10◦C.X-raycrystallographyofthesecrys-
tals was carried out with a Bruker APEXII CCD area detector
using graphite monochromised Mo Kα (γ = 0.71073 ˚ A)
radiation. Data reduction was performed using SAINT soft-
ware, and structures were solved by direct methods using
SHELXS-97.
2.9. Determination of IC50 Values of the Bioactive Compound.
Determination of IC50 for antifungal activity of the bioactive
compound was done according to the standard M38-A
method (NCCLS) with the compound used as the antifungal
agent (concentration range 0.04μg/mL to 10μg/mL) and
amphotericin B as a positive control. Meanwhile, for deter-
mination of IC50 value for P388 activity, the same method as
in P388 cytotoxicity assay was employed with the bioactive
compoundtestedatconcentrationsrangingfrom1.99μg/mL
to 4.10μg/mL. Calculation of the IC50 values was based on
linear regression of plotted data.
3. Results
3.1. Isolation and Preliminary Screening of Endophytic Fungi.
A total of 23 endophytic fungal isolates were isolated from
C. mollissimum; 18 isolates were recovered from the leaves
and 5 isolates from the plant stem. All fungal isolates were
screened for antimicrobial activity. Four of the endophytic
fungal isolates inhibited growth of bacteria and/or fungi
(Table 1). Of these, only one isolate, CB 007 (WA), inhibited
the growth of both bacteria (B. subtilis) and fungi (A. niger
and A. fumigatus); therefore, this isolate was selected for
further experimentation.
3.2. Biological Activity of CB 007 (WA). Fractions of
CB 007 (WA) crude fungal extract obtained via HPLC were
evaluatedforantimicrobial andcytotoxicactivity.Of88frac-
tions tested, three factions were cytotoxic to P388 cells, while
17 fractions inhibited growth of Bacillus subtilis,8f r a c t i o n s
inhibited growth of Aspergillus fumigates, and 3 fractions
inhibited growth of Aspergillus niger. Of these fractions, only
one fraction (C7) exhibited antibacterial, antifungal, and
cytotoxic activity (Table 2) .T h eU Vp r o ﬁ l eo ft h i sf r a c t i o n
indicated the presence of one major compound (result not
shown).
3.3. Identiﬁcation of the Bioactive Compound. Mass spec-
trometry, NMR analysis, and crystal structure determination
revealed the pure compound in fraction C7 as 5-hydroxy-
ramulosin.
5-Hydroxyramulosin (Figure 1): white crystals; UV
(MeOH) λmax 202,265,301.HRESIMSm/z 199.1101[M+H]+.
O
O
H
CH3
OH
OH
Figure 1: Chemical structure of 5-hydroxyramulosin C-carbon, H-
hydrogen, O-oxygen.
Formula: C10H14NO4, M = 198.21. Crystals forming condi-
tion: 1:1 ACN: H2Oa t8 – 1 0 ◦C.
3.4. IC50Values of the Bioactive Compound. The bioactive
compound was also bioassayed to conﬁrm its activity. The
pure 5-hydroxyramulosin compound inhibited A. niger and
was cytotoxic to P388 murine leukemic cells with IC50 values
of 1.56μg/mL and 2.10μg/mL, respectively.
4. Discussion
Cinnamomum species is popularly used in herbal medicines
due to its various therapeutic properties. Usually, essential
oils from the leaf, inner bark, and stems of the plant have
been used in herbal preparations [10]. On the other hand,
endophytic microorganisms which occur in almost all plants
are known to possess pharmacological properties. Therefore,
themedicinalpropertiesofaplantmayberelatedtoitsendo-
phytes. Endophytes from Cinnamomum species have been
studied previously [19, 20]. However, there is no study to
date on endophytes from C. mollissimum.
In the present study, 23 fungal strains were isolated from
C. mollissimum, of which 17.3% (4 isolates) demonstrated
antimicrobial activity in preliminary screening. The agar-
based screening assay employed is an easy method to identify
active isolates for further experimentation and has been rec-
ommended as a rapid protocol in natural product research
which enables determination of antimicrobial activity when
a panel of pathogens are used [21]. One of the isolates,
CB 007 (WA), which has not been identiﬁed yet but is mor-
phologically similar to a Phoma sp., inhibited the bacteria B.
subtilis and pathogenic fungi A. fumigatus and A. niger.A s
CB 007 (WA) was the isolate with the most broad-ranging
activity, it was selected for further investigation to determine
its bioactive component.
The approach taken to identify the active compound
produced by the fungal isolate CB 007 (WA) was bioassay
guided, where fractions of crude fungal extract were evalu-
ated for biological activity prior to puriﬁcation and struc-
tural elucidation of the compound in the active fraction.
A microtiter-plate-based assay was employed in this study
to test the HPLC fractions of crude fungal extract. This
is an eﬀective method to identify highly active fractions,
subsequently reducing the time needed to isolate an active4 Evidence-Based Complementary and Alternative Medicine
Table 1: Antimicrobial activity of endophytic fungi isolated from C. mollissimum. Target organisms were T01-S. aureus, T02-B. subtilis,
T03-E. coli, T04-P. aeruginosa, T05-C. albicans, T06-A. niger, T07-T. viridae, T08-F. Solani, and T09-A. fumigatus (+: inhibition observed
and −: no inhibition).
Endophytic fungal isolates T01 T02 T03 T04 T05 T06 T07 T08 T09
CB 008 (WA) −−−−−−−−−
CL 017 (WA) −−−−−−−−−
CL 015 (WA) −−−−−−−−−
CL 013 (WA) −−−−−−−−−
CL 018 (WA) −−−−−−−−−
CL 002 −−−−−−−−−
CL 005 −−−−−−−−−
CL 019 (WA) −−−−−−−−−
CL 008 −−−−−−−−−
CL 012 (WA) −−−−−−−−−
CL 014 (WA) −−−−−−−−−
CL 003 −−−−−−−−−
CL 009 −−−−−−−−−
CB 002 −−−−−−−−−
CB 001 −−−−−−−−−
CL 006 −−−−−−−−−
CL 010 −−−−−−−−−
CB 006 (WA) −−−−−−−−−
CL 012 −−−−−−−−−
CL 011 + − ++−−−−−
CL 007 + − ++−−−−−
CB 007 (WA) − + −−−+ −−+
CL 016 (WA) −−−−−+ −−−
Table 2: Biological activity of an HPLC fraction from CB 007 (WA) fungal crude extract. Results are expressed as % of target cells inhibited.
Assay Fraction tested Target cells Cells inhibited (%)
Antibacterial activity C7 B. subtilis 96.10
Gentamycin (positive control) B. subtilis 97.00
Antifungal activity C7 A. niger 43.10
Amphotericin b (positive control) A. niger 96.6
Cytotoxicity C7 P388 murine leukemia cells 88.60
compound.Thefractionswerealsoevaluatedforcytotoxicity
against murine leukemic cells in order to select for fractions
containing compounds with the most promising activity. As
endophytes are known to produce a plethora of secondary
metabolites [22], it is very likely that one organism is able to
produce several active compounds. The most active fraction
(C7) of the fungal extract displayed antibacterial, antifungal,
and cytotoxic activity. This activity was consistent with the
fungal isolate’s antimicrobial activity in the initial agar plate
based screening assay, except the fraction did not inhibit A.
fumigatus. Nevertheless, other fractions of the crude extract
were active against A. fumigatus (results not shown).
Puriﬁcation and analysis of the active C7 fraction lead
to the structural elucidation of 5-hydroxyramulosin which
is a polyketide produced via pentaketide synthase action.
Compoundsgroupedaspolyketidesaresigniﬁcantinnatural
product research because of their biosynthetic complexity
and value in pharmaceutical industries. The polyketides
comprise of toxins, antibiotics, therapeutic compounds, fun-
gal melanins, and other pigments [23]. In fungi, pentaketide
synthase is involved in the synthesis of metabolic precursors
of melanin [24]. The cultureCB 007 (WA) produces melanin
when it grows mature (more than 14 days). The production
of melanin in a fungus aids its survival especially under
stressful conditions and increases its virulence potential [25,
26]. This may explain the biological activity observed in the
fungal culture when it was initially screened in agar plate-
based assay. Although 5-hydroxyramulosin is a product of
pentaketide synthase, it is not known if this compound is
involved in melanin synthesis.Evidence-Based Complementary and Alternative Medicine 5
Fraction C7 which contained 5-hydroxyramulosin was
initially observed to have inhibitory activity against B. sub-
tilis, A. niger, and P388 murine leukemic cells. Nevertheless,
when the pure compound 5-hydroxyramulosin was assayed
against the same test subjects, inhibition was only detected
for A. niger and P388 murine leukemic cells. The fraction
may have contained a mixture of compounds, where the in-
hibitory eﬀect against B. subtilis was due to the presence of
otherunidentiﬁedcompoundinthefraction.However,when
5-hydroxyramulosin was puriﬁed, it was ensured that only
thiscompoundwascollectedmanually.5-Hydroxyramulosin
was previously identiﬁed in a marine-derived fungus Phoma
tropica,andthecompoundwastestedforinhibitionofHIV-1
reverse transcriptase enzyme [27].
5. Conclusion
An endophytic fungus isolated from the terrestrial medici-
nal plant Cinnamomum mollissimum produced 5-hydroxy-
ramulosin, a polyketide compound that had antifungal and
cytotoxic activities. This compound may have pharmaceuti-
cal potential as it is highly active at low concentrations and is
the major bioactive metabolite produced by the fungus.
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